Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
buthionine sulfoximine glutathione

buthionine sulfoximine glutathione (BSO) decreases intracellular (GSH) resistant human breast cancer cells Sigma-Aldrich ʟ-Buthionine-sulfoximine, CAS 83730-53-4, ≥97%

Sigma Aldrich Buthionine sulfoximine, CAS 83730 53 4, 97% (TLC) 500 mg Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L buthionine sulfoximine Cell Death & Differentiation Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal

SKU: 67251161130 · From www.marsberger-treibhaus.de

4.0
USD24.69 USD71.69

Pay in 4 interest-free payments of $6.17 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

Use this apparatus with Automate path length, quadrant occupancy, platform crossings, and probe trial heatmaps from overhead video

buthionine sulfoximine glutathione (BSO) decreases intracellular (GSH) resistant human breast cancer cells Sigma-Aldrich -Buthionine-sulfoximine, CAS 83730-53-4, 97%

During this step, adenosine from ATP is transferred to the sulfur in Met through the action of methionine adenosyltransferase (Lauinger and Kaiser, 2021)

buthionine sulfoximine glutathione (BSO) decreases intracellular (GSH) resistant human breast cancer cells Sigma-Aldrich -Buthionine-sulfoximine, CAS 83730-53-4, 97%

While At GSTU7 preferentially retained the protoporphyrin conjugate ( 2 ), At GSTU19 showed a marked preference for the harderoporphyrin ( 1 ) derivative

buthionine sulfoximine glutathione (BSO) decreases intracellular (GSH) resistant human breast cancer cells Sigma-Aldrich -Buthionine-sulfoximine, CAS 83730-53-4, 97%

Mobile Web Portale Plattformen Desktop Backend Schnittstellen IIoT KI Ui/UX Sie suchen eine Digitalisierungslsung oder mchten Knstliche Intelligenz sinnvoll in Ihrem Unternehmen einsetzen

buthionine sulfoximine glutathione (BSO) decreases intracellular (GSH) resistant human breast cancer cells Sigma-Aldrich -Buthionine-sulfoximine, CAS 83730-53-4, 97%
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products